Merck image

Merck releases insomnia drug in US

February 4, 2015
Sales and Marketing FDA, Merck, belsomra, insomnia, orexin, suvorexant

Merck’s insomnia drug Belsomra is now available in the US to treat patients who have difficulty falling asleep or staying …

oliver_zuhlke

New chairman for Bayer’s Central Works Council

February 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Zühlke, Thomas de Win, central works council

Oliver Zühlke has succeeded Thomas de Win as chairman at the Central Works Council of Bayer as he steps down …

Mylan image

Mylan buys into women’s health

February 3, 2015
Sales and Marketing Abbott, FDA, India, Mylan, famy care, female, women

Mylan is to acquire a number of women’s healthcare companies from Indian-based Famy Care that will build upon its 2008 …

Glyxambi image

Boehringer and Lilly score FDA yes for Glyxambi

February 3, 2015
Sales and Marketing Boehringer, FDA, Glyxambi, Tradjenta, empagliflozin, jardiance, lilly, linagliptin

The FDA has approved Glyxambi (empagliflozin/linagliptin), which has become the first combination of two diabetes drugs in their different classes …

affrezza image

Sanofi’s inhalable insulin goes on sale in US

February 3, 2015
Sales and Marketing Afrezza, FDA, Mannkind, Sanofi, US, apidra, diabetes, insulin, type 1, type 2

Sanofi has launched its inhalable insulin Afrezza in the US to control blood sugar in people with type 1 and …

andrew_smith

Sucampo Pharma names new CFO

February 3, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing andrew smith, sucampo

US firm Sucampo Pharmaceuticals has appointed Andrew Smith from within its ranks to fulfill the role of chief financial officer. …

FDA fast-tracks Roche lung cancer drug

February 2, 2015
Sales and Marketing Cancer, FDA, MPDL3280A, Roche, bladder, lung, oncology, pdl1

Roche will be celebrating after its investigational cancer drug MPDL3280A has been fast-tracked by the FDA for the second time. …

Takeda image

Takeda scraps vaccine trial in Phase II

February 2, 2015
Research and Development, Sales and Marketing Diptheria-Tetanus-acellular Pertussis (DTaP) and Sabin inactivated poliovirus vaccine (sIPV), Rajeev Venkayya, TAK-361S, Takeda

Takeda has announced it is abandoning the development of a vaccine in Japan that was in Phase II clinical trials.TAK-361S, …

Sun Pharma and Ranbaxy merger gets US nod

February 2, 2015
Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent

The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …

Shire image

Shire drug approved for binge eating disorder

February 2, 2015
Sales and Marketing ADHD, FDA, Shire, Vyvanse, binge, eating, lisdexamfetamine dimesylate, obesity

Shire has become the first company to gain FDA approval for a treatment for binge eating disorder (BED) in adults …

Stephen Whitehead image

Stephen Whitehead: pharma has transformed

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, Stephen Whitehead, lgbt, pharma

According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …

samantha_bremner_pforbes

Packer Forbes Communications hires director

February 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, samantha bremner

Samantha Bremner has joined healthcare comms firm Packer Forbes as an associate director and member of the agency’s leadership team.

Tamiflu image

Government spending on Tamfilu is justified

January 30, 2015
Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency

The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …

BMS image

BMS wins FDA approval for HIV pill

January 30, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, FDA, Gilead, Reyataz, atazanavir, cobicistat), evotaz, tybost

Bristol-Myers Squibb has earned FDA approval for its HIV combination treatment Evotaz. The US drugs regulator gave BMS the go-ahead …

Patients lack data confidence in NHS

January 30, 2015
Medical Communications, Sales and Marketing Astellas, NHS, care data, data, online, privacy

A recent pharma survey has found that a majority of Britons lack confidence in the NHS to keep their personal …

Google image

Google partners with Biogen on multiple sclerosis

January 30, 2015
Medical Communications, Sales and Marketing Biogen, MS, calico, conrad, google, google x, scangos

Google is making further headway into healthcare by teaming up with Biogen Idec in order to study what leads to …

andrew_cheng

Gilead makes two senior promotions

January 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, andrew cheng

Gilead Sciences has promoted Dr Andrew Cheng to the position of executive vice president, HIV therapeutics and development operations, and …

Ebola vaccine image

Scientists warn Ebola virus is mutating

January 29, 2015
Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, Institut Pasteur, J&J, JJ, guinea

Researchers in France studying the Ebola epidemic say the virus has mutated making it potentially even more contagious. Scientists based …

GSK image

GSK-Novartis mega-deal signed-off by EC

January 29, 2015
Research and Development, Sales and Marketing Abbott, GSK, Mylan, Novartis, acquisition, etc, merger

The European Commission has approved a GSK-Novartis M&A deal, in which GSK will purchase Novartis’ vaccines unit and Novartis will …

The Gateway to Local Adoption Series

Latest content